Public Speaking

June 16, 17 and 18, 2025
"Is RWE always a last resort?"
"RWD Traceability: Challenges and solutions when generating RWE"
"RWE applications - knowing when they work, when they don't, and why."
Drug Information Association Global Annual Meeting, Washington, DC

December 9-10, 2024
"Why cardiologists should care about RWD..." and more
21st Global Cardiovascular Clinical Trialists Forum (CVCT), Washington DC

October 17 20, 2024"Using patient-generated health data for more nuanced clinical outcomes for medical product development"
Markets and Markets 7th Annual RWE & Life Sciences Analytics Conference, Boston, MA

Recordings & Interviews

Dr Nancy Dreyer Highlights the Advantages of a Direct-to-Patient Approach in Observational Research
ISPOR: The International Society for Pharmacoeconomics and Outcomes Research
May 7, 2024

VIEW THE INTERVIEW

Risk management planning and risk minimization measures of cell and gene therapy products
Korea Institute of Drug Safety and Risk Management
September 7, 2023

VIEW THE PRESENTATION

The Evidence Base: Patti Peeples speaks with Nancy A Dreyer. August 21, 2023

VIEW THE INTERVIEW

Using person-generated health data in pharmacoepidemiology: Power to the People

16th Annual Harry Guess Memorial Lecture
April 23, 2023

VIEW THE PRESENTATION